InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by HAUSMAN DIANA. Officer active across 1 company, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 3 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €39k. Activity tracked since 8 May 2023. The latest transaction was disclosed on 9 May 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations